Abstract
Painful distal sensory neuropathy is the most common neurological complication of HIV1 infection. There are several neuropathic pain syndromes associated with the disease; however, the most common is a sensory neuropathy called HIV sensory neuropathy (HIV-SN). HIV-SN can be subdivided into subacute or chronic distal sensory polyneuropathy (DSP) and subacute antiretroviral-induced toxic neuropathy (ATN). Both forms involve sensory loss and neuropathic pain. DSP occurs in up to 7–35% of HIV1-infected individuals and upwards of 34% of children infected with HIV1, while ATN develops following highly active antiretroviral therapy (HAART) treatment in up to 52% of patients. The mechanisms of HIV-SN remain unclear; however, the advent of several models of HIV1-associated peripheral neuropathy is helping unlock the mysteries surrounding HIV-SN. This chapter describes the known pathology of HIV1 and the resulting neuropathy syndromes, including descriptions of the models used to study this particular type of neuropathic pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Herzberg U, Sagen J (2001) Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol 116:29–39.
Keswani SC, Pardo CA, Cherry CL, Hoke A, McArthur JC (2002) HIV-associated sensory neuropathies. AIDS 16:2105–2117.
Romero-Sandoval EA, Horvath RJ, DeLeo JA (2008) Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs 9:726–734.
Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, Epstein L, Kieburtz K (2002) Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 58:1764–1768.
Keswani SC, Jack C, Zhou C, Hoke A (2006) Establishment of a rodent model of HIV-associated sensory neuropathy. J Neurosci 26:10299–10304.
White FA, Feldman P, Miller RJ (2009) Chemokine signaling and the management of neuropathic pain. Mol Interv 9:188–195.
Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21:5027–5035.
Bhangoo S, Ren D, Miller RJ, Henry KJ, Lineswala J, Hamdouchi C, Li B, Monahan PE, Chan DM, Ripsch MS, White FA (2007) Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain 3:38.
Bhangoo SK, Ren D, Miller RJ, Chan DM, Ripsch MS, Weiss C, McGinnis C, White FA (2007) CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav Immun 21:581–591.
Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RJ, White FA (2009) Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain 5:48.
Keswani SC, Polley M, Pardo CA, Griffin JW, McArthur JC, Hoke A (2003) Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 54:287–296.
Miller RJ, Jung H, Bhangoo SK, White FA (2009) Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 194:417–449.
Joseph EK, Chen X, Khasar SG, Levine JD (2004) Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107:147–158.
Dalakas MC (2001) Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 6:14–20.
Flatters SJ, Bennett GJ (2006) Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122:245–257.
Devor M (2006) Sodium channels and mechanisms of neuropathic pain. J Pain 7:S3–S12.
Martin TJ, Eisenach JC (2001) Pharmacology of opioid and nonopioid analgesics in chronic pain states. J Pharmacol Exp Ther 299:811–817.
Rowbotham DJ, Peacock JE, Jones RM, Speedy HM, Sneyd JR, Morris RW, Nolan JP, Jolliffe D, Lang G (1998) Comparison of remifentanil in combination with isoflurane or propofol for short-stay surgical procedures. Br J Anaesth 80:752–755.
Eisenberg E, River Y, Shifrin A, Krivoy N (2007) Antiepileptic drugs in the treatment of neuropathic pain. Drugs 67:1265–1289.
McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA (1996) A systematic review of antidepressants in neuropathic pain. Pain 68:217–227.
Kingery WS (1997) A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73:123–139.
Lawson K (2008) Pharmacological treatments of fibromyalgia: do complex conditions need complex therapies? Drug Discov Today 13:333–340.
Wallace VC, Blackbeard J, Segerdahl AR, Hasnie F, Pheby T, McMahon SB, Rice AS (2007) Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 130:2688–2702.
Wallace VC, Blackbeard J, Pheby T, Segerdahl AR, Davies M, Hasnie F, Hall S, McMahon SB, Rice AS (2007) Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 133:47–63.
Milligan ED, Mehmert KK, Hinde JL, Harvey Jr. LO, Martin D, Tracey KJ, Maier SF, Watkins LR (2000) Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 861:105–116.
Milligan ED, O’Connor KA, Nguyen KT, Armstrong CB, Twining C, Gaykema RP, Holguin A, Martin D, Maier SF, Watkins LR (2001) Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 21:2808–2819.
Spataro LE, Sloane EM, Milligan ED, Wieseler-Frank J, Schoeniger D, Jekich BM, Barrientos RM, Maier SF, Watkins LR (2004) Spinal gap junctions: potential involvement in pain facilitation. J Pain 5:392–405.
Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, Quan N (2005) Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci 22:1977–1986.
Schoeniger-Skinner DK, Ledeboer A, Frank MG, Milligan ED, Poole S, Martin D, Maier SF, Watkins LR (2007) Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav Immun 21:660–667.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Bhangoo, S.K., Petty, L., White, F.A. (2011). Animal Models of HIV-Associated Painful Sensory Neuropathy. In: Ma, C., Zhang, JM. (eds) Animal Models of Pain. Neuromethods, vol 49. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-880-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-880-5_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-879-9
Online ISBN: 978-1-60761-880-5
eBook Packages: Springer Protocols